Gilead Sciences (GILD) EVP converts 6,002 RSUs, with 2,908 shares withheld

Gilead Sciences, Inc.'s EVP, Keeley M Cain Wettan, reported the conversion of 6,002 restricted stock units (RSUs) into common stock on August 10, 2026. Of these, 2,908 shares were withheld at $133.06 per share to cover exercise price or tax liability. Following this transaction, Ms. Wettan holds 13,995 restricted stock units and 8,454 common shares directly.